EVA Pharma launches international-quality inhaler treatments
01
CONTACT US
Book a Meeting
02
ABOUT US
In the presence of Dr. Mohamed Awad Tag El-Din, professor of pulmonary diseases and adviser to the president for health affairs , Dr. Adel Khattab, professor of pulmonary diseases at Ain Shams University and a member of the Supreme Committee for Respiratory Viruses at the Ministry of Higher Education, and Dr. Mohamed Hantira, professor of pulmonary diseases at the Faculty of Medicine at Tanta University, EVA Pharma has introduced two new inhaler treatments to control chest allergy diseases and chronic obstructive pulmonary disease. The first product, Salmetocort, contains a number of active substances, including fluticasone propionate (cortisone) and salmeterol. The second product, Inhalex spray, contains the active ingredient tiotropium.
We empower the fight for health and well being as a human right.
Subscribe for our latest news and updates
For adverse events reporting, please contact us on
PV.Report@evapharma.com
